Search

David Lapinsky Phones & Addresses

  • 8990 Meadow Oaks Dr, Allison Park, PA 15101 (412) 548-3468
  • 14107 Britoak Ln, Houston, TX 77079 (281) 597-0599
  • 32 Over Ridge Ct, Baltimore, MD 21210
  • Westerville, OH
  • 15556 State Route 691, Nelsonville, OH 45764
  • Fleetwood, PA
  • Reading, PA
  • Columbus, OH
  • Lititz, PA
  • 8990 Meadow Oaks Dr, Allison Park, PA 15101

Work

Position: Medical Professional

Education

Degree: Graduate or professional degree

Resumes

Resumes

David Lapinsky Photo 1

David Lapinsky

View page
Skills:
Customer Service
Management
Microsoft Excel
Microsoft Office
Microsoft Word
Powerpoint
Research
Outlook
Process Improvement
Public Speaking
Strategic Planning
Windows
Training
David Lapinsky Photo 2

David Lapinsky

View page
Skills:
Customer Service
Microsoft Excel
Microsoft Word
Powerpoint
Microsoft Office
Photoshop
Leadership
English
Strategic Planning
David Lapinsky Photo 3

Intern At Joe's Pub At The Public Theater

View page
David Lapinsky Photo 4

Assistant Professor At Duquesne University

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
David J. Lapinsky
Phd
Duquesne University
College/University
3319 Latonia Ave, Pittsburgh, PA 15216

Publications

Us Patents

Anti-Cancer Tamoxifen-Melatonin Hybrid Ligand

View page
US Patent:
20130072539, Mar 21, 2013
Filed:
Oct 12, 2010
Appl. No.:
13/497954
Inventors:
Vicki L. Davis - Seven Fields PA, US
David Lapinsky - Allison Park PA, US
International Classification:
C07D 209/20
A61P 35/00
A61K 31/4045
US Classification:
514415, 548507
Abstract:
A particularly constructed tamoxifen-melatonin hybrid ligand gives new and unexpectedly improved results in the prevention and treatment of cancer, particularly breast cancer. The hybrid ligand comprises either tamoxifen or 4-hydroxy-tamoxifen and also melatonin, with the tamoxifen or 5-hydroxy-tamoxifen and melatonin's being linked by an unsubstituted C-Calkyl liner between the tamoxifen amine and the carbonyl of melatonin.

Cocaine Antagonist/Antidepressant Pharmaceutical Preparations

View page
US Patent:
20120322824, Dec 20, 2012
Filed:
Dec 14, 2011
Appl. No.:
13/325618
Inventors:
Christopher K. Surratt - Pittsburgh PA, US
Jeffry D. Madura - Pittsburgh PA, US
Martin Indarte - Buenosaires, AR
David Lapinsky - Allison Park PA, US
Jeffery Talbot - Bluffton OH, US
International Classification:
A61K 31/445
A61P 25/30
A61P 25/24
US Classification:
514317
Abstract:
The present invention is a psychostimulant antagonist or antidepressant in pharmaceutical unit dosage form—with each unit dosage form containing in an effective amount to treat cocaine or amphetamine dependence in an animal or human in which such treatment is indicated and to whom one or more such unit dosage forms are administered—comprising one or more substituted or unsubstituted diphenyl piperidine derivative active agents according to Formula I:including a diastereomer or enantiomer thereof, together with one or more pharmaceutically acceptable excipients or diluents.
David J Lapinsky from Allison Park, PA, age ~49 Get Report